MRC1 and malignant colon neoplasm: The risk of colorectal cancer in individuals with EPCAM deletions is comparable to those with MMR pathogenic variants in LS, whereas the cumulative risk of extra-colonic cancer is much lower compared to those with MMR pathogenic variants in LS [5].